Options for design of real-world impact studies of single-dose vaccine schedules

Based on existing evidence for efficacy, savings, and advantages in delivery, some countries may elect to pilot or roll out single-dose human papillomavirus (HPV) vaccination (instead of, or in combination with, two-dose) in advance of a WHO policy decision. Accelerated evidence of population-based...

Descripción completa

Detalles Bibliográficos
Autores principales: Franceschi, Silvia, Clifford, Gary M., Baussano, Iacopo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6066174/
https://www.ncbi.nlm.nih.gov/pubmed/29571973
http://dx.doi.org/10.1016/j.vaccine.2018.02.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6066174/
https://www.ncbi.nlm.nih.gov/pubmed/29571973
http://dx.doi.org/10.1016/j.vaccine.2018.02.002

Ejemplares similares